Concepedia

Peter Maimonis

PM

Statistics

Publications

14

Citations

690

H-Index

13

Active since

1981

Affiliations

Dana-Farber Cancer Institute(Current)

Friedrich-Alexander-Universität Erlangen-Nürnberg

United States Department of Veterans Affairs

Providence VA Medical Center

Corning (United States)

Peter Maimonis is an author at Dana-Farber Cancer Institute specializing in oncology, medicine, and tumor immunology.

Publications per year

1981–2016

14

Publications

14

Mucins bearing the cancer-associated sialosyl-Tn antigen mediate inhibition of natural killer cell cytotoxicity.

Shunji Ogata, Peter Maimonis, Steven H. Itzkowitz · PubMed · 1992 · 121 citations

Life Sciences, Immunology, Oncology +14

Tumor selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigen.

Lucien Perey, Daniel F. Hayes, Peter Maimonis et al. · PubMed · 1992 · 104 citations

Life Sciences, Molecular Biology, Oncology +17

Comparison of Methods of Measuring HER-2 in Metastatic Breast Cancer Patients Treated With High-Dose Chemotherapy

Lyndsay N. Harris, Vlayka Liotcheva, Gloria Broadwater et al. · Journal of Clinical Oncology · 2001 · 98 citations

Medicine, Cancer Biology, Oncology +16

Elevated soluble MUC1 levels and decreased anti-MUC1 antibody levels in patients with multiple myeloma

Steven P. Treon, Peter Maimonis, Deborah Bua et al. · Blood · 2000 · 84 citations

Medicine, Immunology, Oncology +10

Influence of circulating c-erbB-2 serum protein on response to adjuvant chemotherapy in node-positive breast cancer patients

Tanja Fehm, Peter Maimonis, Stephen Weitz et al. · Breast Cancer Research and Treatment · 1997 · 69 citations

Medicine, Oncology, Breast Oncology +13

1–5 of 14